Transmission and excretion of Eimeria acervulina in vaccinated broiler flocks by Zijlmans, R.







Research Internship Veterinary Medicine 
Robin Zijlmans
21 June – 10 September 2010

Utrecht University 
Department of Farm Animal Health











Aims and scope of this study	9
Materials and methods	11
Chickens and management	11
Eimeria strains and inoculation protocols	12
Vaccine and vaccination protocol	12
Field strain and challenge protocol	12
Experimental design	13










Transmission and infection delay time	18
Results	19
Excretion	19























Appendix 2 Oocyst output results of the McMaster counting chamber and sedimentation–flotation technique for the vaccination period	40
Oocyst output results for group 2	40
Oocyst output results for group 3	41
Oocyst output results for group 4	42
Appendix 3 Oocyst output results of the McMaster counting chamber and sedimentation–flotation technique for the challenge period	43
Oocyst output results for groups 1A and 1B	43
Oocyst output results for groups 2A and 2B	44
Oocyst output results for groups 3A and 3B	45
Appendix 4 Deaths	46
Appendix 5 Stable design	47
Vaccination period stable A	47
Vaccination period stable B	48
Challenge period stable A	49
Challenge period stable B	50





	Coccidiosis is an economically important disease in chickens, caused by infection with Eimeria species. Due to increasing resistance against anticoccidials and European legislation to forbid prophylactic in-feed medication by 2012, alternatives for the current control strategy with anticoccidials in feed should be considered. Vaccination might be a good alternative, but is not often applied in broilers due to high costs and disappointing results.
	Suboptimal results of vaccination might be caused by insufficient uptake of vaccine by part of the flock, due to mass application. However, this was not studied to this date. Studying transmission of vaccine or field strains can increase knowledge on infection dynamics in vaccinated flocks, which might contribute to optimalisation of vaccine programs. Therefore, an experiment was carried out where transmission and excretion of vaccine and field strains were examined and effects on body weight were assessed. 
	The experiment consisted of a vaccination period from days 2-27 and a challenge period from days 28-49 of age. On day 2 of age, 88 SPF broilers were divided in four groups of 22 animals: group 1 remained unvaccinated (NV, control group). In groups 2-4 half of the flock (11 animals) was vaccinated (Vaccinated, V birds) with 600 sporulated E. acervulina oocysts of the Paracox vaccine (Intervet). The other 11 birds of each group were sham vaccinated with water (Contact-Vaccinated, CV birds). In the challenge period, birds from groups 1-4 were divided into eight groups of 10 birds. Groups 2A, 3A, 4A consisted of V birds and groups 2B, 3B and 4B of CV birds. Groups 1A and 1B consisted of NV birds. In all groups, except 4A and 4B (unchallenged vaccinated controls), five birds per group were challenged (inoculated, I birds) with 5000 sporulated oocysts of a field strain of E. acervulina and five were not (contact-inoculated, CI birds). Individual droppings were examined daily from days 5-49 to determine OPG (number of oocysts per gram of faeces). The total infection delay time, i.e. time between expected and actual start of excretion added for all CV or CI birds per group, was determined as a measure for transmission of the Eimeria strain. Body weights were determined on day 0 and weekly from day 2-49. 
	In the vaccination period, all 11 CV birds became infected and total infection delay times were, 16, 12 and 18 days for groups 2, 3 and 4 respectively. The peak of output was significantly higher for CV birds compared to V birds. In the challenge period, all CI birds became infected and total infection delay time was zero days for groups 1A, 1B (NV) and 3A (V), one day for groups 2B and 3B (CV) and nine days for group 2A (V). Total oocyst output after challenge infection by NV birds was significantly higher compared to CV or V birds but was not significanty different between CV and V birds or between CI and I birds. A significant difference in body weight between V and CV birds was only found at day 7 after vaccination, when V birds showed a slight growth check. During the challenge period, body weights could not be compared due to large differences in cage conditions. 
	From these results it can be concluded that direct or contact-vaccination apparently could not reduce the (rate of) transmission of the field strain of E. acervulina, but did reduce oocyst output after challenge compared to non-vaccinated birds. When birds were not directly vaccinated but were into contact with vaccinated birds, i.e. contact-vaccinated, a similar degree of protection against high oocyst output after challenge infection occurred. 






Coccidiosis, caused by protozoa of the genus Eimeria, is a major problem in the poultry industry. Its estimated annual cost worldwide differs between 800 million US dollars [Allen 2002] to 2400 million USD [Shirley 2005]. Seven species of Eimeria are important to chickens: E. acervulina, E. tenella, E. mitis, E. praecox, E. maxima, E. necatrix and E. brunetti [Allen 2002, Vermeulen 2001, Shirley 2005, McDougald 2003]. The first five are especially a problem in the broiler industry; E. necatrix and E. brunetti are more often seen in layers and breeders [McDougald 2003].
Control of coccidiosis is especially a problem in the broiler industry, because the animals have a short lifespan, and therefore the time to build up immunity against Eimeria species is limited. Also the warm environment and high stocking density are favourable conditions for coccidiosis [Shirley 2005]. Furthermore, the economic margins of poultry production are relatively small for the broiler industry. Consequently, the costs for control of coccidiosis are relatively high and the benefits are relatively small for broilers, compared to layers and breeders.
Williams [1999] calculated in 1995 that 18% of the costs of coccidiosis in broilers are for prophylaxis and therapeutic intervention; poor performance (mortality, reduced growth and feed conversion) accounts for 81% of all costs.
Coccidiosis gives economical losses as well as welfare impairment to the chickens. The symptoms caused by this parasite consist of bloody diarrhoea, dehydration, impaired growth, reduced feed efficiency and sometimes even death [Allen 2002, Williams 1999, McDougald 2003].
Nowadays applying coccidiostatic drugs in the feed is the most common way of dealing with this problem [Allen 2002, Shirley 2005, Chapman 2005, Peek 2009]. Furthermore, therapeutic application of anticoccidial drugs can be considered. However, because of increasing resistance of the parasite to many of these drugs [Chapman 2005, Peek 2009], as well as an European law to forbid prophylactic use of anticoccial drugs as feed additives [Chapman 2005], which might pass in 2012, other alternatives of opposing this disease have to be developed and evaluated. Vaccination is a promising alternative to the use of anticoccidial drugs [Allen 2002, Chapman 2005] and is applied in some poultry sectors but is used only sparingly in de broiler industry, possible due to high variability in efficacy and limited economic benefits. In this study vaccination of small broiler flocks will be studied, especially with regard to effects on spread, oocyst output and body weight. This approach might contribute to the knowledge on and evaluation of vaccination as a control strategy in broiler flocks.

Coccidiosis
Coccidiosis is primarily a disease of young animals [Vermeulen 2001, McDougald 2003]. Newly hatched birds, however, may not be fully susceptible due to the presence of maternal antibodies or because their gizzard can not crush the oocysts to release the sporozoites. Finding oocysts in the droppings of broilers is most common between the ages of 3-6 weeks; they are rarely found before 3 weeks [McDougald 2003].
The host-parasite interactions are complex; genetic background and infection history of the host, and species and strain of the parasite have their influence on the build up of immunity [Shirley 2005]. 
Immunity is induced most potently in the early part of the life cycle when the sporozoite may invade villus enterocytes, crypt enterocytes and intraepithelial lymphocytes. All of these host-parasite interactions could be critical for the induction of immunity [Shirley 2005]. The sexual stages in the development of Eimeria species are probably less important for induction of immunity, although involvement of these stages have been shown [Rose 1987]. The T-cells in the GALT (Gut-associated-lymphoid-tissue) are the primary effectors of the immune response; antibodies play a minor role [Allen 2002]. 
Chickens develop solid immunity to homologous secondary infections [Rose 1987]. The dose is of influence in the build up of immunity as a higher dose gives a better immunity [Williams 2001]. Furthermore, repeated exposure to oocysts is also an important factor for development of immunity. Therefore it is a self-limiting disease; the oocyst shedding declines after a period of time in which the immunity is induced. Immunosuppressive diseases such as Marek’s disease may interfere with the development of immunity [McDougald 2003]. No cross-immunity exists between different species of Eimeria. This means that when a second outbreak of coccidiosis occurs in the same flock, another Eimeria species is most likely responsible for it [McDougald 2003]. As avian coccidia are highly immunogenic, and primary infections can stimulate solid immunity to homologous challenges, it would seem obvious that vaccines could offer excellent alternatives to drugs as a means of controlling coccidiosis [Allen 2002].

There is no intermediate host for Eimeria species; the most common means of spread is mechanical: persons, animals (birds and insects), contaminated equipment and dust. The only natural method of transmission is oral ingestion of sporulated oocysts. The sporulation process can take up to two days, but can vary considerably depending on all kinds of parameters, like temperature and relative humidity, described by Graat et al [1994]. A small proportion of oocysts can most likely sporulate within hours, as was shown in other experiments by our group [Velkers 2010a]. Susceptible birds in the flock most likely ingest the oocysts by contamination of food or drinking water or litter-pecking.

When oocysts are ingested, the oocyst wall is crushed in the gizzard. Chymotrypsin, bile salts and CO2 release the sporozoites from sporocysts in the small intestine. The sporozoites enter epithelial cells or are taken into intraepithelial lymphocytes, where development may begin. After at least two generations of asexual development (i.e. schizogony), a sexual phase occurs. This consists of microgametes uniting with macrogametes. The resulting zygote matures into an oocyst, which is released from the intestinal mucosa and is shed in the faeces. This whole process (prepatent period, PPP) takes 4-6 days, depending on the species of Eimeria (see figure 1) [Allen 2002, McDougald 2003]. 
Infected chickens may shed oocysts in the faeces for several days or weeks [McDougald 2003].  Maximum oocyst output ranges from 6 to 9 days post infection [Allen 2002]. A higher ingested dose results in higher oocyst excretion, until a certain threshold value [Velkers 2010a, Williams 2001]. 




































Figure 1. Life cycle of Eimeria spp. in chickens.
1 After oral uptake of sporulated oocysts the sporozoites hatch in the small intestine from the sporocysts. 2–6 After penetration,multinucleate schizonts are formed (3) inside a parasitophorous vacuole (PV). The schizonts produce motile merozoites (DM,M), which may initiate another generation of schizonts in other intestinal cells (2–5) or become gamonts of different sex (7, 8). 7 Formation of multinucleate microgamonts, which develop many flagellated microgametes (7.1-7.2). 8 Formation of uninucleate macrogamonts, which grow to be macrogametes (8.1) that are characterized by the occurrence of two types of wall-forming bodies (WF1, WF2). 9 After fertilization the young zygote forms the oocyst wall by consecutive fusion of both types of wallforming bodies (FW). 10 Unsporulated oocysts are set free via faeces. 11–13 Sporulation (outside the host) is temperature dependent and leads to formation of four sporocysts, each containing two sporozoites (SP), which are released when the oocyst is ingested by the next host.
DG, developing microgametes; DM, developing merozoite; DW, developing wall-forming bodies; FW, fusion of WF1 to form the outer layer of OW; M, merozoite; N, nucleus; NH, nucleus of host cell; OW, oocyst wall; PB, polar body (granule); PV, parasitophorous vacuole; R, refractile (= reserve) body; SB, sporoblast; SP, sporozoite; SPC, sporocyst; SPO, sporont; WF1, wall-forming bodies I; WF2, wall-forming bodies II; Z, cytoplasm of zygote (= young oocyst) (Mehlhorn, 2001). [Peek 2009]

According to Williams [1999] coccidia can interfere with their host in three ways:
1.	Infection which leads to clinical symptoms as described above;
2.	Infection which leads to subclinical coccidiosis; this is economically important, due to reductions in weight gain and efficiency of feed conversion;
3.	The host is infected by a few parasites, but this has no effect on the animal, this situation is sometimes called coccidiasis.
Also it may allow the colonization by harmful bacteria, for instance Clostridium perfringens or Salmonella typhimurium [McDougald 2003], which can exacerbate symptoms.

Oocysts are very resistant to disinfectants; therefore the parasite will not be killed by good cleaning alone. Oocysts can survive for great periods of time under optimal conditions, but can be killed by exposure to temperatures above 55 degrees Celsius (or 37 °C for 2-3 days) or by freezing or drying. In poultry litter the survival is limited because of the heat and ammonia. 
Although introduction of coccidiosis into a flock can almost not be prevented, this should not be an excuse to disregard control measures, similar to those preventing other poultry diseases on a farm, to prevent or reduce the chance of introducing Eimeria. They include isolating the birds and separating them from the environment and other animals, like rodents and insects. Trafficking between farms should be limited; and hygiene measures, including disinfection of materials and humans, should be taken [Peek 2009, McDougald 2003].

Control of coccidiosis
Currently, applying coccidiostatic drugs is the most used strategy against this disease [Allen 2002, Shirley 2005, Chapman 2005, Peek 2009]. In 2012, however, a law most likely will be passed in the European Union that makes the preventive use of these drugs through the feed illegal [Chapman 2005]. Furthermore, the efficacy of the use of anticoccidial drugs is limited, due to increasing resistance of the parasite against these drugs [Vermeulen 2001, Chapman 2005, Peek 2009]. Also consumers’ concerns about residues in the human food industry, makes the use of these drugs unwanted [Williams 2002].
Vaccination appears to be a good alternative, although it is not applied very often. The reasons for this are that vaccination is more expensive (12-15 eurocent per broiler [Steenhuizen & Vossen 2001], or the equivalent of 8 pennies [Williams 1999]) compared to costs of medicated feed (2 eurocent per broiler [Steenhuizen & Vossen 2001]. Furthermore, growth and feed conversion in vaccinated flocks are not always better than in flocks treated with coccidiostatic drugs [Williams 2002].
Vaccination in broilers is usually only applied at farms with severe coccidiosis problems. To reduce costs, vaccination is not used in all production rounds, but is applied in a couple of succeeding rounds to improve the sensitivity of the parasite to the coccidiostatic drugs, followed by a couple of rounds with anticoccidial drugs through the feed [Peek 2009].
In the Netherlands the only registered vaccines for broilers against coccidiosis are Paracox-5 and 8 (Intervet-Schering-Plough). Paracox-5 is a live attenuated vaccine with precocious strains of Eimeria acervulina, two different Eimeria maxima strains, Eimeria mitis and Eimeria tenella. It is registered for use at day 3 of age via food or drinking water, but it is also allowed to spray it over the chickens at day of hatch [Fidin 2010]. 
Paracox-8 is a live attenuated vaccine, as well; it contains Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria mitis, Eimeria necatrix, Eimeria praecox and Eimeria tenella. This vaccine is registered for use through drinking water at day 5 till day 9 of age. It is allowed for usage for slaughter- laying- and breeder- chickens [Fidin, 2010]. Paracox-8 is mostly used in the laying and breeder industry; its use in broilers is very limited. 
Both vaccines contain precocious strains of Eimeria species. These strains produce smaller numbers of oocysts (output for E. acervulina is reduced with 7.7% compared to the field strain) due to a shorter endogenous life cycle (less schizont generations or smaller schizonts) [Shirley 2005]. Also, the PPP is shorter (62 hours compared to 89 hours for an E. acervulina field strain) [Shirley and Bedrnik 1997]. The damage by parasite multiplication in the intestines is limited, although Williams demonstrated that lesions appeared in the first multiplication cycle [Williams and Andrews 2001].

In most published studies on vaccination against coccidiosis, the chicks are vaccinated in the first week of age, followed by a challenge after three to four weeks. A week later the growth, feed conversion and other clinical parameters are examined. Williams [2002] has summarized most of these studies. When considering three performance parameters, daily weight gain, feed conversion ratios and mortality, vaccinated birds performed better in 32 out of 43 occasions. However, only 10 out of 43 were significantly different. He concluded that this tends to confirm that, unless drug resistance is a problem, vaccination against coccidiosis does not give a consistent improvement in these parameters. He also concluded from his findings that vaccinated birds tend to have a lower mortality rate than medicated birds (14 out of 17 occasions, but not always significantly different). A depression in growth occurs with the use of non-attenuated vaccine strains, this, however is compensated later on. This growth check is not found in flocks, which are vaccinated with an attenuated strain. 
Under experimental conditions, vaccines are, when applied appropriately, able to induce an adequate immune response. However, when using mass application under field conditions, not all birds in a flock might ingest (a sufficient dose of) the vaccine and consequently some birds in the flock might not be sufficiently protected against an infection with wild type Eimeria species [Williams 2002].
This assumption however, has never been proven, because in all the previously mentioned studies the researchers have strived to vaccinate all chicks. So we do not know whether all individual animals have to receive a sufficient dose in order to sufficiently combat the field strain. Further research to study the uptake of vaccine by birds in a flock and subsequent spread to other birds might be helpful to elucidate this.

For evaluation of control strategies, e.g. vaccination, against infectious agents, transmission studies, which quantify the spread of the agent between animals in a herd or flock, can be very helpful [Velthuis et al, 2007]. Most of the experiments reviewed by Williams [2002] only concentrated on body weight and feed conversion. The disadvantage of doing this is not getting any information about how the parasite spreads through a population; this then remains a “black box”. By understanding more about the spread of the parasite between birds, this might enhance our understanding of how we can influence the dynamical aspects of the disease, which might reveal new approaches to combat the disease. Furthermore, we can develop mathematical models using knowledge of the spread of the parasite, to predict effects of different interventions, without the need to experiment on live animals.

Aims and scope of this study
To contribute to knowledge on spread of Eimeria species in vaccinated flocks, a transmission experiment was carried out with a vaccine strain and a field strain of E. acervulina, to study the associations between transmission and excretion of the vaccine strain and transmission and protection against a field strain after vaccination.
In the first part of this experiment we examined the effect of vaccinating only half the flock on transmission and excretion of the vaccine strain in vaccinated and contact-vaccinated birds. In the second part we focused on transmission and excretion after a challenge with a field strain of E. acervulina. By studying transmission and relating it to oocyst output, the infectivity and susceptibility of vaccinated and contact-vaccinated animals can be compared. Furthermore, body weights were determined throughout the experiment to examine whether transmission, oocyst output characteristics and vaccination and challenge status have an influence on performance of the chicks.

Questions that we aim to answer are:
1.	How fast is the transmission of the vaccine strain from vaccinated (V) to contact-vaccinated (CV) animals?
2.	How do the excretion patterns differ between V and CV birds? 
3.	Can an effect in the vaccination period between V, CV and NV birds on body weight be found?
4.	How quickly is the field strain transmitted from inoculated (I) to contact-challenged (CI) animals? Is transmission of the field strain influenced by the vaccination state?
5.	Does vaccination state give any protection against challenge, when looking at excretion and effects on weight?







A total of 135 male SPF (specific pathogen free) Cobb/Hybro/Ross crossbred broilers were collected at day of hatch at the Animal Health Service (Deventer, The Netherlands) and transported to the Department of Farm Animal Health of Utrecht University (Utrecht, The Netherlands). All animals were individually tagged with a Swiftack label in their neck, weighed and placed into two cages on wood shavings, each containing approximately 70 animals. 
At day 2 of age, at the start of the vaccination period, the birds were randomly divided into four groups (groups 1-4), each consisting of 22 birds. Groups 2, 3, and 4 were placed in the same experimental unit (Stable A). Group 1, the non-vaccinated group, was placed in a different experimental unit (Stable B) to prevent cross-contamination (see Appendix 1 for the different groups and Appendix 6 for the stable designs). Each of these groups was housed in a cardboard box, which served as a cage, with a surface of 1.2 m2 per 22 birds. Each cage contained a layer of wood shavings of 1 kg/m2. This bedding material was not removed, nor was new material added, to prevent any influence on the uptake of oocysts from the environment and transmission. All extra animals were placed in a smaller cardboard box in Stable A. Eighteen of these birds were killed at day 3 of the experiment; the rest at day 19.
In the challenge period from day 28 onwards, eight groups of ten chickens remained; groups 2A, 3A and 4A contained vaccinated birds; groups 2B, 3B and 4B consisted of contact-vaccinated birds and groups 1A and 1B of non-vaccinated birds (see Table 1). Two groups, groups 4A (vaccinated) and 4B (contact-vaccinated birds) were not challenged and were placed in stable B. Each group was housed in a cardboard box of 0.6 m2 per 10 animals filled with 600 gram of clean wood shaving on which the birds were housed until the end of the experiment. The density of birds was approximately 20 birds / m2 throughout the experiment, when corrected for surface reduction due to presence of feed bins, which approximates the density of birds in commercial broiler houses.

At day of arrival the temperature on chick level was 36°C and was decreased according to standard broiler management guides to 21°C towards the end of the experiment, mainly by adjusting the height of heat lights. At day 17 of the experiment, to reduce the occurrence of ascites and flip-overs, a light schedule was implemented in which red lights were on for six hours per day and white lights for 15 hours, followed by a dark period of one hour. At day 25 the red light period was increased to 9 hours and from day 36 onwards to 13 hours a day. 
The RH differed from 52 to 90, but was on average around 70% in stables A and B. For stables A and B the light schedule, temperature, relative humidity (RH) and all other management aspects were attempted to be kept identical, but this was difficult to achieve.

The chickens had unlimited access to water and coccidiostatic-free food (Research Diet Services BV, Wijk bij Duurstede, the Netherlands). The food bins were placed at the appropriate height, according to the size of the animals, to prevent spoilage of food on the litter and contamination of the feed with faeces. Both might influence transmission, due to uptake of oocysts by pecking at the, with faeces contaminated, food or litter, that normally might not have been ingested. For the same reason there were drinking bottles installed instead of water buckets, except for the first 3 days. From day 3 onwards drinking bottles were installed and at day 5 water buckets were removed.

Hygienic procedures were very important; these existed of the following: before entering the stable clean clogs, gloves, overalls, hair caps were applied and all materials introduced into the stables had to be cleaned and disinfected with 10% of an ammonium hydroxide solution first. The route was always from stable B to stable A, because stable B contained the non-vaccinated and later during the experiment the non-challenged groups. 

The birds were observed twice a day for signs of illness or welfare impairment and were housed, handled and treated following approval by the Animal Experimental Committee of Utrecht University (Utrecht, The Netherlands), in accordance with the Dutch law on experimental animals. 
All chickens were killed at day 49 by cervical dislocation.


Eimeria strains and inoculation protocols
Vaccine and vaccination protocol
The chickens were vaccinated by means of oral application of the Eimeria acervulina strain from Paracox-5 (REG NL 9687 UDA) vaccine. The recommended dose for each chick is 0.004 ml of the vaccine, which would result in a dose of 500-650 sporulated E. acervulina oocysts per chick. For this experiment, only the E. acervulina strain of the vaccine, kindly provided by Intervet, was used.
At day 2 of the experiment, all 22 birds that were randomly assigned to group 1, were placed in stable B, after giving a sham-vaccination with 0.42 ml of water. Groups 2, 3 and 4 were randomly divided in vaccinated (V birds) or contact-vaccinated animals (CV birds). All the 11 to-be CV animals were given a sham-vaccination with 0.42 ml of water and were placed in one cage, G1 (1.2 m2). The sham-vaccination was given before preparation of the vaccine to prevent cross contamination to NV or CV birds. All the 33 to-be vaccinated birds were placed in another cage, K1 (0.6 m2). Then the vaccine solution was prepared.
From the primary suspension that Intervet provided, a dilution with water was made. A 30% sucrose solution was added in a 1:1 dilution with the diluted vaccine suspension to obtain an even distribution of oocysts in the final suspension. In all solutions, including the final solution, the number of oocysts per ml was assessed with a Fuchs-Rosenthal counting chamber. 
The birds were inoculated with 600 sporulated E. acervulina vaccine oocysts in 0.42 ml suspension. The mixture was gently suspended for every two or three syringes: 11 syringes were filled for each group. The birds were vaccinated orally with a 1 ml syringe with a crop needle attached and were placed back in their box after vaccination. All the vaccinated animals were temporarily placed in cage K1 to prevent contamination of non-vaccinated animals with the oocysts that could have been spilled around the beak of the bird during the inoculation or that could have been regurgitated. Twenty-four hours later, at day 1 post-vaccination (day 1 pv, day 3 of age), V birds were housed together with CV birds, each group consisting of 11 V and 11 CV birds in a 1.2 m2 cage. 

Field strain and challenge protocol
At day 28 of the experiment, the animals were randomly assigned to the eight different groups in the challenge period. Groups 2A, 3A and 4A contained vaccinated birds; groups 2B, 3B and 4B consisted of contact-vaccinated birds and groups 1A and 1B of non-vaccinated birds. 
In this period groups 1A, 1B, 2A, 2B, 3A and 3B were housed in stable A; groups 4A and 4B that did not receive a challenge infection, were placed in stable B.
The five (groups 3A and 3B) or six (groups 1A, 1B, 2A and 2B) to-be inoculated birds (I) of each group were placed in six temporary cages in the front of the stable. The 5 to-be contact-inoculated (CI) birds of each group were placed in six cages (0.6 m2) in the back of the stable. The Weybridge strain of E. acervulina, kindly provided by Animal Health Service (Deventer) was used for the challenge inoculum. The inoculum was prepared as described above for the vaccine inoculum. The animals were inoculated with 4934 sporulated oocysts in 1.10 ml suspension.
On day 1 post-challenge (day 1 pc, day 29 of age), I birds were placed in the cage of the CI birds, resulting in six groups of 10 (groups 3A and 3B) or 11 (groups 1A, 1B, 2A and 2B) birds in a 0.6 m2 cage, where they would remain until the end of the experiment at day 49. One animal of each group in which six animals were inoculated, was killed at day 31 (day 3 pi).

Experimental design
The experiment consisted of a vaccination period, from days 2-27 of age and a challenge period, from days 28-49. The experimental design is summarized in Table 1 and explained below.

At the start of the vaccination period, at day 2 of age (dag 0 pv) the birds were randomly divided into four groups, each consisting of 22 birds:
1)	Positive control group: Non-vaccinated, Challenged, NC
2)	Vaccinated, Challenged, VC
3)	Vaccinated, Challenged, VC
4)	Negative control group: Vaccinated, Non-challenged, VN
Fifty per cent of the birds of groups 2, 3 and 4 chosen randomly by the internet program Random Integer Generator (http://www.random.org/integers/ (​http:​/​​/​www.random.org​/​integers​/​​)) were vaccinated on day 2 of age. Group 1 and the other 50% of each group received a “sham-vaccination”. At day 3 of age (day 1 pv) the 22 animals (11 vaccinated and 11 non-vaccinated) were placed in their final cages in which the birds stayed for the remainder of the vaccination period.
The transmission of the vaccine strain and oocyst excretion was determined by collecting daily individual droppings, starting at day 3 pv. Individual droppings have shown to be representative of oocyst shedding per day [Velkers 2010b]. These droppings were collected and examined by the McMaster (McM) or sedimentation-flotation (SF) method as described below.

At the start of the challenge period, at day 28 of age (day 0 pc), the animals were challenged with the Weybridge strain. The classification of birds in the challenge period is as follows:
1)	NC: Non-vaccinated, Challenged/Inoculated
	A. 11 non-vaccinated animals: 6/11 animals challenged (NV-I) / 5/11 animals
			contact-challenged (NV-CI)
	B. 11 non-vaccinated animals: 6/11 animals challenged (NV-I) / 5/11 animals
			contact-challenged (NV-CI)
2)	VC: Vaccinated, Challenged
	A. 11 vaccinated animals: 6/11 challenged (V-I) / 5/11 animals contact
 			challenged (NV-CI)
	B. 11 contact-vaccinated animals: 6/11 challenged (CV-I) / 5/11 animals
			contact-challenged (NV-CI)
3)	VC: Vaccinated, Challenged
	A. 10 vaccinated animals: 5/10 challenged (V-I) / 5/10 animals contact
			challenged (NV-CI) 
	B. 10 contact-vaccinated animals: 5/10 challenged (CV-I) / 5/10 animals
			contact-challenged (NV-CI)
4)	VN: Vaccinated, Non-challenged
	A. 11 vaccinated animals: no challenge
	B. 11 contact-vaccinated animals: no challenge (see Table 1)

Group	# of birds	Vaccination1	Spread vaccin / OPG3	Weight / FCR4	Challenge2	Spread challenge/OPG3	Weight / FCR4
1: Non-vaccinated Challenged (NC)	22	11 birds non-vaccinated (NV)11 birds non-vaccinated (NV)		Weekly			
1A					5 NV-birds challenged (NV-Ino)5 NV-birds non-challenged (NV-Contact)	Yes	Weekly
1B					5 NV-birds challenged (NV-Ino)5 NV-birds non-challenged (NV-Contact)	Yes	Weekly
2: Vaccinated Challenged (VC)	22	11 birds vaccinated (V)11 birds non-vaccinated (CV)	Yes	Weekly			
2A					5 V-birds challenged (V-Ino)5 V-birds non-challenged (V-Contact)	Yes	Weekly
2B					5 CV-birds challenged (CV-Ino)5 CV-birds non-challenged (CV-Contact)	Yes	Weekly
3: Vaccinated Challenged (VC)	22	11 birds vaccinated (V)11 birds non-vaccinated (CV)	Yes	Weekly			
3A					5 V-birds challenged (V-Ino)5 V-birds non-challenged (V-Contact)	Yes	Weekly
3B					5 CV-birds challenged (CV-Ino)5 CV-birds non-challenged (CV-Contact)	Yes	Weekly
4: Vaccinated Non-Challenged (VN)	22	11 birds vaccinated (V)11 birds non-vaccinated (CV)	Yes	Weekly			
4A					5 V-birds non-challenged (V)5 V-birds non-challenged (V)		Weekly
4B					5 CV-birds non-challenged (CV)5 CV-birds non-challenged (CV)		Weekly
Total birds/samples	88		66	88/4		60	80/8
Table 1. Experimental design






The transmission and oocyst excretion of the field strain in groups 1A, 1B, 2A, 2B, 3A and 3B was checked by collecting and examining daily individual droppings, from day 3 pc onwards until the end of the experiment according to the same procedures as after the vaccination.

Body weight was determined at day 0; birds that had a body weight under 25 grams were excluded from the experimental groups. Body weight of the birds was recorded at days 0, 2, 9, 16, and 23 during the vaccination period and at days 30, 37, 44 and 49 (day of euthanasia) during the challenge period. 


Collection and examination of faecal samples 
Collection procedure
In the vaccination period, individual droppings were collected and examined daily from V birds from day 5 of age (day 3 pv) and from CV birds from day 7 (day 5 pv) onwards for groups 2-4. From day 13 (day 11 pv) onwards V birds and from day 20 (day 18 pv) onwards CV birds were sampled every other day and later on there were two days between two successive samples (see Appendix 3). Group 1 was sampled weekly from day 10 (day 8 pv) onwards using pooled samples of at least 10 droppings, collected from the surface of the litter.

During the challenge period, individual droppings were collected and examined daily from I birds from day 31 (day 3 pc) and from CI birds from day 35 (day 7 pv) onwards. Groups 4A and 4B were sampled at days 31 (day 3 pc) and 48 (day 20 pc) individually and pooled samples from the litter were examined at days 38 (day 10 pc) and 44 (day 16 pc). 

After turning the lights off at approximately 7.00 am for about 15 minutes, each chick was placed in a cat carrier box, lined with clean water resistant bitumen paper, for approximately 2 hours every day. Most chicks produced a dropping during this period. The dropping was collected in a tube that was weighed before and after collecting the sample.




When it was unknown whether an animal was shedding oocysts, the sedimentation-flotation (SF) method, according to Long et al. [1976], was used as a screening procedure. SF has a lower detection limit than the McMaster procedure. Briefly, approximately 1 gram of faeces was mixed with 80 or 100 ml water and put through a sieve. This suspension was transferred (mid-stream) into a centrifuge tube and centrifuged for 5 minutes at 1500 g. The supernatant was removed; the sediment was left in the centrifuge tube. A sodium chloride solution (specific gravity 1.2) was added till ¾ of the tube was filled. Then, when necessary, the content of the tube was thoroughly mixed. When the tube was placed in the centrifuge, more sodium chloride solution was added, until a meniscus appeared. A cover slip of 18 x 18 mm was placed on top of the meniscus and slightly pushed. This was centrifuged for 5 minutes at 1000 g. The cover slip was placed on a microscope slide and was studied under a light microscope using a 10 x 10 magnification. The samples were qualified as slightly positive (+), positive (++) or very positive when many oocysts were present (+++) or negative (-). 
McMaster (McM)
To quantify oocyst production, the McMaster counting chamber technique was used according to a modification of the technique described by Long and Rowell [1957]. Briefly: 20 ml of a sodium chloride solution (specific gravity 1.1) was added to the faecal sample after recording the weight of the sample. 
After homogenization, 2 ml of the suspension was transferred into a centrifuge tube filled with 8 ml of a saturated sodium chloride solution (specific gravity 1.2). This suspension was used to fill two McMaster counting chambers (2 x 0.15 ml). Further 10-fold dilutions were made if more than 300 oocysts were present per chamber. The number of oocysts per gram of faeces (OPG) was calculated: 333.3ab/sample weight (a is the total number of oocysts in both chambers; b is the dilution/10). The detection limit when a = 1 using this modified McMaster technique is 83 OPG for a 4 g faecal sample.

Choice of test
SF was performed on all samples that were expected to be negative or low positive and when positive, the McM was done to count the exact number of oocysts. When birds were expected to be positive, first a McM was performed and when negative, the SF was carried out. 





To facilitate the statistical analyses, a specific code (daycode 0 to 8) was given to each day of weighing: 
	0 = 6 July 2010 = day 0 of the experiment
	1 = 8 July 2010 = day 2 of the experiment = day 0 pv
	2 = 15 July 2010 = day 9 of the experiment = day 7 pv
	3 = 22 July 2010 = day 16 of the experiment = day 14 pv
	4 = 29 July 2010 = day 23 of the experiment = day 21 pv

 	5 = 5 August 2010 = day 30 of the experiment = day 2 pc
	6 = 12 August 2010 = day 37 of the experiment = day 9 pc
	7 = 19 August 2010 = day 44 of the experiment = day 16 pc
	8 = 24 August 2010 = day 49 of the experiment = day of euthanasia

The vaccination state was expressed by 0, 1 and 2. Non-vaccinated (NV) is 0; contact-vaccinated (CV) is 1; vaccinated (V) is 2.
In the challenge period, 0 represents non-challenged (non-inoculated, NI), 1 is contact-challenged (contact-inoculated, CI), and 2 is challenged (inoculated, I).

Oocyst output
For each bird and each faecal sample the number of oocysts per gram of faeces (OPG) was calculated in Excel (Microsoft Excel, 2003). From these data, some new variables were created for further analyses. These included:
	OPGinclSF: if the SF test showed negative results, the oocyst count (OPG) was considered to be zero; 
	logOPGinclSF: the OPGinclSf was log10 transformed to normalize the data, and was used to obtain oocyst excretion patterns for the different groups per day;
	AUC: a measure for total output of each bird per day was created by calculating the area under the curve (AUC) of oocyst excretion. The AUC is calculated according to the following equation: 
  				∆ AUC = OPGinclSFday x  + OPGinclSFday x-1 * day x -day x-1 / 2 
The AUC is calculated for each bird by cumulating the ∆ AUC values of preceding days;

	logAUC: the AUC was log10 transformed to normalize the data. This parameter was used to calculate the means per group and type of bird and was used in the further statistical analyses 

	Distinctions were made between different periods in the vaccination period:
	Logaucpeak: the logAUC was calculated for days 5-9 for V birds and days 9-13 for CV birds, which represents the first peak of oocyst output for V and CV birds respectively. 
	Logauctotal: the logAUC of the total oocyst excretion during the vaccination period (i.e. AUC at day 25 of the experiment). 
	Logaucday 9: the logauc after the first peak of excretion of V birds at day 9. This output is solely a result of the vaccination on day 2 of the experiment, as CV birds had not started excreting oocysts yet at this time.
	Logaucday13: the logauc after the first peak of excretion of CV birds at day 13.
	Logaucday9-25: the logAUC for the period between day 9-25 was calculated. For comparisons between V and CV birds, the total oocyst output can not be used, as V animals shed for a longer period of time than CV birds. The AUC between day 9-25 represents oocyst output for V and CV birds after the first peak of V birds (as a result of inoculation with the vaccine strain) had passed. During this period, both types of birds were exposed to the same level of oocysts from the environment, with the only difference that V birds have been vaccinated and CV birds were not. 
	For the challenge period the following period was defined:
	Logauctotalcorr: the logauc for I birds of day 46 of the experiment and for CI birds logauc of day 49 was used as a measure for total output during the challenge period, corrected for the fact that I birds could start with oocyst excretion 3 days before CI birds.

For the statistical analysis of AUC data, students t tests and ANOVA were carried out in SPSS (SPSS 16.0 for Windows) to determine differences in means between different groups and types of birds. Linear (mixed) models (Proc GLM and Proc Mixed) were carried out in SAS (SAS 9.2. for Windows) do determine whether associations could be found between AUC for the different periods (dependent variable) and vaccination state, day of the experiment and challenge state as explanatory variables. Corrections for repeated measurement were not applicable, as the AUC is cumulative and only one AUC per bird was used in the analysis. Corrections for cage effects were made in the mixed models by entering cage as a random factor. When differences between groups were analysed, generalized linear models were used, as a correction for cage effects was not applicable.

Body weight
For the statistical analysis of body weight, the female birds were excluded. Students t tests and ANOVA were carried out in SPSS (SPSS 16.0 for Windows) to determine differences in means between different groups and types of birds. 
Linear mixed models (Proc Mixed) were carried out in SAS (SAS 9.2. for Windows) do determine whether associations could be found between vaccination state, day of the experiment and challenge state as explanatory variables and body weight as dependent variable. Bird number was entered in the model as “subject” with an autoregressive covariance structure to correct for repeated measurement for the same bird on different weighing days. Cage and stable were entered as random factors to correct for the differences in conditions between cages and stables that might have an influence on body weight. 
 
Model fit
The two-tailed partial F-test (type III) was used as the elimination criterion for the variables and fit of the model was assessed by the Akaike’s Information Criterion (AIC) for linear mixed models. Bonferroni corrected pair-wise multiple t tests were carried out to test the difference between each pair of means. Model assumptions were evaluated by examining normality and equality of variances of the residuals. P values < 0.05 were considered significant.

Transmission and infection delay time
Transmission of the parasite was quantified for groups 1-4 using the following measures:
	Total number of infected contact birds per group
	Infection delay time per contact-vaccinated or contact-challenged bird and the total infection delay time per group
The infection delay time is defined as the number of days between the first day a contact-vaccinated or contact-inoculated bird could have started excreting oocysts and the actual day oocysts were detected in the faeces for the first time.
For contact-vaccinated birds, the first day at which contact birds could have started shedding oocysts was day 8 (dag 6 pv). Based on time of vaccination and times of sampling, the PPP of the vaccine strain must have been between 47-69 hours (according to literature 72 hours) after vaccination, as V birds first excreted oocysts from day 5 (day 3 pv) onwards. When sporulation time is considered negligible the first excretion for CV birds would be detectable from day 8 (day 6 pv) onwards, which was confirmed by our data. A few samples contained some (mostly sporulated or damaged) oocysts before day 8 but were considered false positive.
For contact-challenged, CI birds, the first possible day of start of output was day 35 (day 7 pc). I birds started shedding between 70-94 hours pc. When sporulation time is considered negligible the first excretion for CV birds would be detectable from day 35 (day 7 pc) onwards, which was confirmed by our data.
In this challenge period a less critical point of view was taken to decide whether or not samples were false or actually positive. Samples with small numbers of oocysts were considered positive, because partly immune birds, would probably only shed a few oocysts at the start of excretion. Whereas in the vaccination period, samples with small numbers of oocysts before day 8 were considered false positive, as the birds were naïve and should start excreting with a high output from the beginning. 










Start of excretion and infection delay time
In Appendix 2 and 3 the McM and SF test results per day of the experiment, the number of infected contact-vaccinated and contact-challenged birds and infection delay times per bird and total infection delay time per group are shown for the vaccination and challenge period respectively. 
Vaccination period 
At day 5 of age (day 3 pv), one V bird of group 2, six V birds from group 3 and six in group 4 started oocyst excretion. From day 6 of age (day 4 pv), onwards, all V birds were excreting oocysts. 
CV birds started shedding at day 8 (n=4), day 9 (n=13), day 10 (n=15) and day 11 (n=1), i.e. on days 6, 7, 8 and 9 pv. At day 8, only one bird of group 2 and three birds of group 3 started shedding; group 4 had no positive CV birds yet. At day 10 all animals, except bird 38 (group 4), were excreting oocysts. Bird 38 started at day 11. The total infection delay time for CV birds from group 3 (12 days) was much shorter than infection delay times in groups 2 (16 days) and 4 (18 days).
Challenge period
I birds started shedding oocysts at day 32 (n=17), day 33 (n=11) and day 34 (n=2), i.e. on days 4, 5 and 6 pc. At day 32, three animals of group 1A and five of group 1B; one of group 2A and three of group 2B; four of group 3A and one of group 3B started excreting oocysts. At day 33 the last two I birds of group 1A started excretion, as well as the last bird of group 3A, the final four of group 3B; and the last two of group 2B. Two I birds from group 2A did not show detectable oocyst output until day 34. 
CI birds started excreting at days 35 (n=24), day 36 (n=4), day 38 (n=1), and day 39 (n=1), i.e. on days 7, 8, 10 and 11 pc. At day 35, all CI birds of groups 1A and 1B started excreting oocysts, as well as all birds of group 3A. The total infection delay time for CI birds of groups 1A and 1B (NV) and 3A (V) was zero, as all CI animals of these groups were infected at the first moment they could have been infected (day 35).
In group 3B and 2B (CV birds), four birds started shedding at day 35; the fifth bird of each group started excreting the next day (day 36). The total infection delay time for groups 3B and 2B was one day.
In group 2A, only one animal excreted oocysts at day 35. At day 36 two birds of this group started shedding and at days 38 and 39 the remaining two birds started respectively. The calculated total infection delay time for the CI birds of group 2A (V) was nine days.
Oocyst output
Vaccination period
In figure 2A the oocyst shedding of all groups (mean of the log10 transformed OPG values, logOPGinclSF) is shown for all days of the entire vaccination period, and in figures 2B-2D for groups 2, 3 and 4 separately. 
For V birds the first peak of oocyst excretion starts three days after the vaccination on day 5 (day 3 pv); for CV animals the first peak starts at day 9 (day 7 pv). For both vaccination states the peak’s duration is approximately four days. The V animals show a second peak in output, coinciding with the first peak of shedding of the CV birds, followed by a rapid decline in oocyst output. The CV birds do not have a second excretion peak and the decline in shedding after the peak is more gradual compared to the V birds. 

In table 2, mean and confidence intervals for the total oocyst output, oocyst output between day 9-25 and the first peak of output are summarized for the different groups and bird types. 

Total oocyst output did not differ significantly between V and CV animals for all groups together (P=0.1212). When analysed per group, total oocyst output was significantly higher in CV birds compared to V birds in group 3 (P=0.0420).
Total oocyst output of the V birds did not differ significantly between groups 2, 3 and 4, whereas for CV birds significant differences between the different groups were found. Total oocyst output for CV birds of group 4 was significantly lower compared to CV birds in groups 2 and 3. 

The first peak of oocyst output was significantly higher for CV compared to V birds when no distinction is made between the groups (P-value <0.0001).
When analyzed per group, the peak of CV birds of groups 2 (P=0.0002) and 3 (P<0.0001) is significantly higher compared to V birds. In group 4, peaks of V and CV birds were not significantly different (see also figure 2D). 

After the first peak of excretion of V birds at day 9, no significant differences were found between the three groups of V birds in the total output until that day (logaucday9). This output is solely a result of the vaccination on day 2 of the experiment, as CV birds had not started excreting oocysts yet at this time.
After the first peak of excretion of CV birds at day 13, total output of CV birds (logaucday13) of group 4 was significantly lower compared to CV birds of groups 2 (P<0.0001) and 3 (P=0.004). 

In the period between day 9-25, when V and CV birds were comparable for their exposure level to oocysts from the environment, CV animals have a significantly higher output than V birds (P= 0.0027). When analyzed per group, oocyst output from day 9-25 was only significantly higher in CV birds compared to V birds for group 3 (P=0.0071).



















































In figure 3A oocyst shedding (mean of the log10 transformed OPG values, logOPGinclSF) for CI and I birds and in figure 3B for NV, V and CV birds is shown for all days of the entire challenge period. Figures 4A and 4B show the mean output of the CI birds and I birds of all groups, divided by vaccination state (NV, V and CV).

For I birds the peak of oocyst excretion starts 3 days after inoculation at day 32; for CI birds the first peak starts at day 35. The peak of oocyst excretion, however, shows no difference between CI and I animals. 
The NV birds show a higher oocyst excretion compared to CV and V birds. Moreover do NV animals start sooner and show a steeper slope. This applies for both CI and I birds as shown in figures 4A and 4B.

In table 3, mean and confidence intervals for the total oocyst output (corrected) are summarized for the different groups and bird types. 

Total oocyst output (Logauctotalcorr) corrected for earlier start of excretion of I birds, did not differ significantly between CI and I animals (P=0.353). 
When analysed by different vaccination state, the NV birds shed significantly more oocysts than CV or V birds (P<0.000). Between CV and V animals no significant difference in total oocyst output was found.






Figure 3. The mean oocyst output for CI (green) and I (yellow) birds (A) and for NV (0=blue), CV (1=green) and V (2=yellow) birds (B) for the challenge period.






























In table 3, the mean and confidence intervals for body weights for the different days of the vaccination period are summarized for the different groups and bird types. 

Figure 5A shows the mean body weight for groups 1, 2, 3 and 4 for days 0, 2, 9, 16 and 23 (daycodes 0-4) respectively. In Figure 5B mean body weights are given for NV, CV and V birds. 























At none of the five weighing moments during the vaccination period a significant difference was found between the four different groups (Figure 5A and Table 3).
When analysed for the three vaccination states, day 9 is the only moment during the vaccination period, where a significant difference between NV, CV and V animals occurs. V birds had a significantly lower weight than the CV (P=0.0014) and NV (P=0.0046) animals, when corrections were made for repeated measurement, cage and stable differences. Even without these corrections the difference was significant (Figure 5B and Table 2). When the analyses were done for the entire vaccination period, no significant differences in body weight were found between NV, CV and V birds. 


In figure 6 the mean body weight is shown for groups 2, 3 and 4 for days 0, 2, 9, 16 and 23 (daycodes 0-4) for the different vaccination states (NV, CV and V birds).

Figure 6. The mean body weight of groups 2, 3 and 4 for days 0, 2, 9, 16 and 23 (daycodes 0-4) divided by vaccination state, i.e. CV (1=blue) and V (2=green) birds.





In table 3, the mean and confidence intervals for body weights for the different days of the challenge period are summarized for the different groups and bird types. Figure 7 shows the mean body weights for NV, CV and V birds for days 30, 37, 44 and 49 (daycodes 5-8) respectively. 















In Figure 8 the body weights for the 8 different groups during the challenge period are shown.













When a division is made between the eight different groups in a linear mixed model (with corrections for repeated measurements per bird and influence of the stable) it becomes clear that the differences at days 37 and 44 are most likely caused by group 3A. The V birds of group 3A have a significantly lower body weight compared to V birds of group 4A and CV birds of groups 1B, 3B and 4B on day 37. On day 44 differences were found with V birds of group 2A and with CV birds of groups 2B, 3B and 4B. On day 49 body weight of birds in group 3A was significantly higher compared to all other groups. 






No statistical significances in body weight, based on different challenge states of the animals (non-challenged, groups 4A and 4B), challenged (I birds) and contact-challenged (CI birds), were found at any day during the challenge period (Figure 9). 
























Tabel 2. Mean body weights and oocysts output for the different groups in the vaccination period (day 2-27) 

VACCINATION PERIOD	 	Mean Body Weight (95% CI)
Group	Vacc A	Name	#B	Day 0C	Day 2	Day 9	Day 16	Day 23
1	0	NV	19	29,89 (28,88-30,91)	42,84 (41,71-43,98)	164,11 (157,50-170,71)	395,37 (380,08-410,66)	776,74 (747,89-805,58)
2	1	CV	11	29,82 (28,11-31,53)	42,36 (41,20-43,52)	160,73 (152,04-169,42)	404,36 (380,35-428,38)	762,00 (724,82-799,18)
 	2	V	11	30,00 (28,51-31,15)	44,00 (42,25-45,75)	153,27 (147,93-158,62)	399,09 (380,95-417,23)	768,00 (740,21-795,79)
3	1	CV	11	29,82 (28,11-31,53)	43,64 (41,82-45,45)	168,36 (157,66-179,06)	426,18 (398,25-454,12)	797,82 (755,58-840,06)
 	2	V	10	30,00 (28,69-31,31)	41,80 (40,44-43,16)	156,00 (149,01-162,99)	402,40 (391,32-413,48)	758,40 (737,98-778,82)
4	1	CV	10	29,80 (28,10-31,50)	43,20 (41,75-44,66)	162,40 (155,77-169,03)a	414,20 (384,14-444,26)	758,60 (727,30-789,90)
 	2	V	11	28,91 (27,58-30,24)	42,91 (41,81-44,01)	149,64 (141,84-157,44)b	392,36 (377,01-407,72)	756,36 (724,42-788,31)
                                                                                                                          AUC (95% CI)
Group	Vacc	Name	# 	meanlogAUCtotal D	#	meanlogAUCpeak1 E	#	meanlogAUCd9-25 F
1	0	NV	19	.	 	.		.
2	1	CV	11	6,07 (5,80-6,34) a	11	5,97 (5,64-6,30) a	11	6,0739 (5,8046-6,3432) a 
 	2	V	11	5,82 (5,54-6,10) ab	11	5,14 (4,98-5,29) b	11	5,6573 (5,3127-6,0018) ab 
3	1	CV	11	5,86 (5,65-6,06)a	11	5,78 (5,54-6,02) a	11	5,8554 (5,6499-6,0608) a
 	2	V	10	5,52 (5,28-5,74) b	11	4,99 (4,83-5,14) b	10	5,3224 (5,0380-5,6067) b
4	1	CV	10	5,29 (5,03-5,53) b	11	5,01 (4,71-5,32) b	11	5,2822 (5,0325-5,5319) b



















Data represent means for V or CV birds and the associated 95% confidence intervals (CI), calculated based on the normal distribution.
A. Vaccination state (0=NV, 1=CV, 2=V)
B. Number of birds per group
C. Day of the experiment
D. Meanlogauctotal: the logAUC of the total oocyst excretion during the vaccination period (i.e. AUC at day 25 of the experiment) 
E. Meanlogaucpeak: the logAUC for days 5-9 for V birds and days 9-13 for CV birds, which represents the first peak of oocyst output 
F. Meanlogaucday9-25: the logAUC for the period between day 9-25 was calculated. During this period, both types of birds were exposed to the same level of oocysts from the environment, with the only difference that V birds have been vaccinated and CV birds were not. 

a–b Values within the same column with different superscripts differ significantly (P < 0.05)


Table 3. Mean body weights and oocysts output for the different groups in the challenge period (day 28-49)
CHALLENGE PERIOD	Mean Body Weight (95% CI)
Group	Vacc A	Chall	Name	# B	Day 30 C	#	Day 37	#	Day 44	#	Day 49
1a	0	1	NV-CI	5	1182,80 (1149,48-1216,12)	5	1430,80 (1386,34-1475,26)ab	5	1775,60 (1646,19-1905,01)ab	5	2042,40 (1928,26-2156,54)b
 	0	2	NV-I	6	1154,00 (1111,83-1196,17)	5	1368,20 (1299,76-1436,64)	5	1806,00 (1740,75-1871,25)	5	1985,20 (1925,49-2044,91)
1b	0	1	NV-CI	3	1132,67 (1072,09-1193,24)	3	1418,00 (1296,46-1539,54)b	2	1482,00 (1470,24-1493,76)ab	2	1699,00 (1650,00-1748,00)b
 	0	2	NV-I	5	1193,20 (1149,01-1237,39)	5	1428,00 (1357,33-1498,67)	5	1864,80 (1758,01-1971,59)	5	2078,00 (1965,18- 2190,82)
2a	2	1	V-CI	5	1144,40 (1116,75-1172,05)	5	1322,00 (1213,50-1430,50)ab	5	1785,20 (1680,48-1889,92)b	5	1942,80 (1867,76-2017,84)b
 	2	2	V-I 	6	1148,00 (1107,54-1188,46)	5	1410,80 (1351,65-1469,95)	5	1880,00 (1769,70-1990,30)	5	2027,60 (1846,99-2208,21)
2b	1	1	CV-CI	5	1113,60 (1100,87-1126,33) 	4	1401,25 (1353,51-1448,99)ab	4	1919,00 (1856,19-1981,81)b	4	2049,50 (2008,72-2090,28)b
 	1	2	CV-I 	6	1116,67 (1055,02-1178,31)	5	1322,40 (1288,33-1356,47)	5	1830,80 (1779,80-1881,80)	5	2062,80 (1992,53-2133,07)
3a	2	1	V-CI	5	1117,60 (1067,06-1168,14)	5	1286,00 (1200,31-1371,69)a	5	1662,00 (1575,41-1748,59)a 	5	1737,20 (1593,87-1880,53)a
 	2	2	V-I 	5	1105,60 (1055,84-1155,36)	5	1280,60 (1249,81-1311,39)	5	1566,00 (1442,51-1689,49)	5	1593,20 (1408,07-1778,33)
3b	1	1	CV-CI	5	1132,40 (1060,85-1203,95)	5	1410,00 (1290,73-1529,27)b	5	1846,80 (1719,49-1974,11)b	5	2039,20 (1941,92-2136,48)b
 	1	2	CV-I 	5	1185,20 (1144,83-1225,57)	5	1519,00 (1431,78-1606,22)	5	1941,60 (1857,29-2025,91)	5	2168,00 (2057,72-2278,28)
4a	2	0	V-NI	10	1130,90 (1083,28-1178,52)	10	1408,30 (1358,28-1458,32)b	10	1720,00 (1618,84-1821,16)ab	9	2033,22 (1877,79-2188,65)b



























The prepatent period (PPP) of the vaccine strain was expected to be 72 hours (personal communication Hay Janssen, Intervet). In samples collected at day 3 pv, which was 69 hours after vaccination, some of the V birds had detectable oocyst output according to the SF test. This indicates that the PPP was shorter than expected based on the suppliers information. Shirley and Bedrnik [1997], however, reported a PPP of precocious E. acervulina strains of 62 hours.
The faeces was examined only once a day, so the actual start of excretion could even have been shorter (i.e. between 45 and 69 hours). However, as the McM counts were not positive on this day and not all V birds were positive yet, it is likely that the excretion just started and therefore the PPP of the vaccine strain was most likely only a few hours shorter than the expected 72 hours.  
The CV birds are expected to start excreting oocysts after sporulation of the oocysts excreted by V birds after the PPP has passed. At day 8, some of the CV birds had positive SF and some of them even positive McM results, which is only 3 days after we detected the first oocyst output in V birds. This suggests that, although average sporulation time for E. acervulina in literature differs from hours to days dependent upon condition [Graat 1994], in this case sporulation time was negligible. Similar results were reported for previous experiments by our group [Velkers 2010a]; sporulation time was assumed to be negligible.  
There were already some positive SF results at day 7, but the oocysts that were found were mostly sporulated or damaged. As it was considered to be impossible for the PPP and sporulation time together to be only 47 hours, these results were regarded as false positive. 
The PPP of the field strain found in this study was between 70 to 94 hours, based on start of output of challenged I birds at day 32. Again, this PPP was shorter than the expected 96 hours reported in the literature. The I birds of groups 1A and 1B (NV) started all, except for two birds, at day 32. We might have missed the oocysts of these two birds that were found positive from day 33 onwards, because they started perhaps an hour later or because of a small amount of faeces. Small amounts of faeces were common, especially in the vaccination period. Consequently, we had to make choices as to what test we would perform. In some instances we had too little faeces to perform both test and in some cases the McM was chosen, and no oocysts could be found. When the SF test would have been chosen, perhaps this test would have been positive. Furthermore, even when only one test was chosen, the amount of faeces might have been too small to detect oocysts in some cases. Therefore, it is possible that samples of some birds were false negative and consequently we might have missed the first day of excretion because of this. Consequently, the calculated infection delay times, might also have been affected.  
In the challenge period, the challenged animals could have started with low excretions, as most birds, except for the birds that were non-vaccinated of group 1, might have acquired some immunity. Luckily in this period the droppings were larger, so mostly we could perform both SF and McM and therefore false negative results were probably rare. 

The total infection delay time of CV birds in the vaccination period for group 3 (12 days) was much shorter than of groups 2 (16 days) of 3 (18 days). This suggests that the vaccine spread faster in group 3, than in the other two groups. 

The CV birds had to ingest the oocysts shed by V animals by litter pecking or by feed, contaminated with faeces. This pecking might be influenced by group interactions, activity and coincidence. The activity level can be influenced by light intensity, differences in behaviour of animals, vitality, disease and quality of bedding and surroundings. However, these factors were not visibly different between the cages. Previous experiments have shown that transmission rates were not influenced by ingested oocyst dose [Velkers 2010a]. Furthermore, the dose excreted by V birds was not significantly different between groups, so the oocyst dose in the environment most likely did not play a role. The higher transmission rate in group 3 is most likely caused by unknown stochastic processes. This same feature might be of influence in the fact that, although for total oocyst output analyses show no significant differences between CV and V animals; in group 3 the output in CV birds was significantly higher than the output in V birds.

Because the oocyst output in all three groups (2-4) of vaccinated birds was equal at day 9 of the experiment, we can conclude that the vaccination technique was reproducible between groups and was executed correctly, as there was no significant difference in the first peak of output between the V-birds of the different groups. 

The total oocyst output produced on day 13, directly after their first peak output, was significantly lower for CV birds of group 4 compared to CV animals of groups 2 and 3. Consequently this follows in a lesser output of CV birds of group 4 in comparison to CV birds of groups 2 and 3, for the total oocyst output and output during days 9-25. Although overall, CV animals showed a significantly higher excretion than the V animals during days 9-25. From this we can conclude that the CV animals of group 4 picked up a smaller amount of oocysts from the environment (“contaminated” with vaccine oocysts by the V birds), compared to CV birds of groups 2 and 3. The V birds did not differ in their amount of oocyst output, so the low output of CV birds could not have been caused by a lower oocyst load in the environment provided by the V birds. A possible explanation is that these birds were less active; perhaps due to differences in behaviour or hierarchy, the temperature in their surroundings or light intensity between groups. However, the stable logbooks do not show any indication that these factors played a role. Another explanation could be that they were more immune to infection. This, however, is unlikely, as they had the same genetic background as the birds in the other groups and furthermore, all birds were randomly assigned to the groups. The actual reason for this difference remains unclear and might be a result of small differences in the dynamical aspects of the flock infection.

The oocyst output of CV birds was significantly higher compared to oocyst output by V birds during the first peak for groups 2 and 3 and for all groups together. Williams [2001] has shown that there is a linear association between input and output of oocysts. This suggests that CV birds probably ingested a higher dose than the 600 oocysts the V birds received during the vaccination. It is also shown that a higher oocyst dose might also induce a higher level of immunity to subsequent challenge [Williams 2001]. Therefore, CV birds might have become more immune to infection than V birds. The data in table 3, however, does not show a lesser oocyst output after challenge for CV birds in comparison to V animals, nor is the infection delay time (see Appendix 3) for CV animals enlarged.
The CV birds of group 4 did not show a significantly higher oocyst shedding than the V birds during the first excretion peak. As discussed above, CV birds in group 4 probably ingested lower numbers of oocysts. 


The differences in oocyst output by CV animals of the three different groups could be caused by the differences in interaction between individuals (infection dynamics) or between differences in housing. We attempted to keep the conditions in the cages and stables as comparable as possible. The three cages in stable A were for the duration of the vaccination period very comparable. 




The spread from I to CI animals was very quick, especially in groups 1A and 1B. For these non-vaccinated groups, the total infection delay time in the challenge period was zero hours. All CI animals were infected at the first moment they could have been infected, i.e. at day 7 pc. The CI animals did not have immunity against infection yet, because of their NV state, so, as expected, these birds were highly susceptible for contracting the infection. Furthermore, the I birds of groups 1A and B were excreting significantly more oocysts than the I birds of the vaccinated and contact-vaccinated groups and consequently they provided a large oocyst load in the environment. This most likely resulted in ingestion of a large number of oocysts by the CI birds of groups 1A and 1B. The higher level of susceptibility of the non-vaccinated CI birds, in combination with the large oocyst load in the environment, resulted in very high oocyst outputs of CI birds of groups 1A and 1B compared to CI birds of contact-vaccinated and vaccinated groups. 

The total infection delay time of group 3A (V) was zero days as well and for groups 3B (CV) and 2B, the total infection delay time was merely one day. The expectation was that in V animals the transmission of the challenge strain would be delayed compared to NV or CV birds, but this expectation was contradicted by these results. However, transmission seemed to have been delayed for group 2A (V) as the infection delay time for this group was nine days. This would suggest that the CI animals in group 2A (V) were better protected than CI birds of group 2B (CV), group 3A (V) and 3B (CV). A better protection against infection could have been induced when the vaccinated animals of group 2A had shed more oocysts in the vaccination period than the V birds of the other groups and therefore had become more immune to infection. This however, can not be the case, because the excretion between the three groups of V birds in the vaccination period was not significantly different.  
Another possible explanation could be that the CV birds of group 2 had shed more oocysts in the vaccination period, which could have enhanced immunity of the V birds. This can not be the reason as well, because there were no significant differences in output of CV birds between groups 2 and 3 and only the CV animals of group 4 excreted significantly lower amounts than groups 2 and 3. A further option might be that the oocyst load in the environment, provided by excreting I birds, was lower in group 2A than in groups 2B, 3A and 3B. 
As discussed above, previous experiments [Velkers 2010a] have shown that the ingested dose did not influence transmission rate. However, for the sake of the discussion, we can explore this option. For instance, the inoculation dose might have been less for I birds of group 2A than for the I birds of the other groups. 
However, oocyst output of I birds of the vaccinated and contact-vaccinated birds were not significantly different so this can also not be an explanation.  
The differences in infection lag times between groups were most likely a result of differences in infection dynamics due to unknown (stochastic) factors.

In the challenge period, challenge state (CI or I) had no effect on oocysts output. The dose of the challenge inoculum was higher than the vaccine dose, so the difference between CI or I was expected to be less than CV or V. The 600 oocysts the V birds were inoculated with, was a smaller number than the dose the CV birds ingested. The 5000 oocysts we inoculated the I animals with, however, is well over the threshold value Williams [2001] described for E. acervulina, therefore the I birds would not shed many more oocysts than this amount of 5000 so the CI birds would probably not ingest many more oocysts than the I birds.





The mean body weight at day of hatch was much lower than we anticipated; the mean was under 30 grams at day 0 (29,75 grams). This was caused by the young age of the broiler breeders. When compared to broiler management guides the average weight at day 0 is around 40-42 grams for male Cobb, Hybro and Ross broilers. This line of SPF broilers was separated from the regular broiler industry a long time ago, so while the industry has selected for better growth and feed conversion, the broilers in this line remained somewhat the same. Therefore the growth is expected to be lower compared to commercial broilers. Consequently, comparisons of the body weight in this experiment with commercial broilers can not be made. 
Although the chickens received feed ad libitum, we provided periods with red light to limit activity and feed intake to reduce the occurrence of deaths due to ascites and flip-overs due to quick growth rates. 

At day 9 of the experiment the body weight of vaccinated animals was significantly lower than for the contact vaccinated birds. This could have been a result of the vaccination. Williams reports in his review [2002] that this growth check only results from vaccination with non-attenuated vaccine strain; in our study an attenuated strain was used, so the depression in growth in our broilers was uncommon. The first peak of oocyst shedding in the vaccinated birds had already occurred at day 9, whereas at that time, CV birds were not yet shedding oocysts. When analyzed per group, the difference between V and CV animals for body weight only appears in group 4. We know that the CV birds of group 4 most likely did not pick up as many oocysts as the CV birds in the other groups, as discussed above. So maybe the body weight of the CV birds of groups 2 and 3 already was somewhat affected by developing schizonts in their intestines, which resulted in slightly lower body weights compared to CV birds of group 4. Consequently, when the CV birds of groups 2 and 3 indeed were slightly limited in their growth, the difference with the V animals in these groups would not be significant. At the end of the vaccination period the V birds and the CV birds did not have significantly different body weights, so compensatory growth had occurred. This is in line with the findings of Williams [2002], i.e. that when a growth check does occur due to vaccination, this is usually compensated later in the production cycle.

Challenge period
In the challenge period a huge effect of the surroundings on the growth of the animals was likely. The box of group 3A was wet, as were the two boxes of groups 4A and 4B. The conditions in these boxes improved, whereas the box of cage 3A remained soaked from day 35 onwards. This resulted in locomotion problems, which might have influenced the feed intake in this group. Wet litter and locomotion problems also occurred to a lesser degree in stable B, where the NV birds of 4A and 4B were housed. 




Attempts were made to keep the conditions in the two stables and in all cages as comparable as possible. Stable B, however, was much harder to ventilate, so both the temperature and the relative humidity fluctuated too much. An ammonia smell was occasionally apparent during the challenge period. Consequently the conditions were not as comparable as thought beforehand. Furthermore, in some cages wet litter was present, which might have affected locomotion and feed intake. Therefore corrections were made for cage and stable effects by using a random factor in the linear mixed models.

Deaths





One of the aims for this experiment was to study the spread of the vaccine from vaccinated (V) to contact-vaccinated (CV) animals. After vaccinating 11 birds of the flock, all 11 CV birds became infected. Transmission was relatively quick; total infection delay times of the three groups were, 16, 12 and 18 days. The ingested dose for the CV birds was probably higher than the 600 oocysts for V birds, as the peak of output was significantly higher for CV birds. This was expected and caused hardly any welfare impairment to CV birds. Furthermore, the higher ingested dose for CV birds compared to V birds did not have an effect on the subsequent response, i.e. total infection delay time or oocyst output, to the challenge infection
Furthermore this study was designed to study the spread of the field strain in birds with a different history of vaccination (NV, CV or V). The delay time of the CI birds in the non-vaccinated groups 1A and 1B was zero, but also group 3A had a delay time of zero days. Groups 2B and 3B had one day delay time; whereas group 2A had a delay time of nine days. Therefore we can conclude that direct or contact-vaccination apparently could not prevent spread of the field strain of E. acervulina. However the CI birds in group 2A (with vaccination as history) were much later infected than the CI birds of all other groups. The reason for this remains unclear and can not be explained by oocyst output dynamics in the vaccination period. 
Vaccination does however provide some protection against oocyst output after a challenge. NV birds have a much higher oocyst output compared to CV or V birds. There is however no difference between the CV and V birds when comparing output after a challenge. The challenge state (CI or I) did not have any effect on excretion, so the dose ingested by CI or I birds probably does not differ much.
A growth check occurred in the vaccinated animals seven days after vaccination compared to CV and NV birds. This is probably due to the vaccination. At the end of the vaccination period the V birds had compensated qua growth, because no differences were found in weight at days 16 and 23 of the experiment. In the challenge period body weights were influenced mainly by cage conditions from day 37 onwards and could not be attributed to challenge or vaccination status.  

It can be concluded that vaccination gives protection against high oocyst shedding after infection with a field strain, and consequently prevents damage to the intestines. Transmission of the field strain, on the other hand, is not delayed by vaccination. It was previously documented and this study confirms that spreading of oocysts throughout a flock will appear independent of the amount of oocysts excreted. Not dose, but opportunity of making contact with contaminated litter or feed, most likely results in transmission. For transmission of the vaccine strain this holds the conclusion that animals should be raised, for the first few days, in a contained space, so the possibility of coming into contact with (vaccine) oocysts is increased. For the transmission of the field strain this would suggest that the broilers should be housed in environment with more space for each individual, so the possibility of coming into contact with contaminated litter would be reduced.

A possibility for future research is vaccinating only 10, 20 of 30% of a flock and examining the transmission and excretion after vaccination and after challenge for NV, CV and V animals; and measuring production characteristics like body weight. Furthermore, as we believe that the probability of coming into contact with infectious material plays and important role, effects of bird density and available space for the birds should be evaluated in these studies as well.  
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Appendix 2 Oocyst output results of the McMaster counting chamber and sedimentation–flotation technique for the vaccination period






2	11	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 * -	 * *	 * *	 * -	 
2	12	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 * -	 * *	 * *	 * -	 
2	21	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 * -	 * *	 * *	 * -	 
2	28	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 * +	 * *	 * *	 * -	 
2	35	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 * +	 * *	 * *	 + +	 
2	61	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 * -	 * *	 * *	 * -	 
2	76	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 * -	 * *	 * *	 * -	 
2	83	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 + *	 * *	 * *	 - +	 * *	 * *	 * -	 
2	95	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 + +	 * *	 * *	 + +	 * *	 * *	 * -	 
2	925	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 + +	 * *	 * *	 + +	 
2	926	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 * -	 * *	 * *	 * -	 
2	3	CV	 	 * *	 * *	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 + *	 * *	 * *	 + *	 * *	 * *	 * -	1
2	18	CV	 	 * *	 * *	 * -	 - *	 * +	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 * *	 * -	1
2	19	CV	 	 * *	 * *	 * -	 - *	 * +	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 * *	 + *	 * *	 * *	 * -	1
2	31	CV	 	 * *	 * *	 * -	 - *	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 + *	 * *	 * *	 * -	2
2	34	CV	 	 * *	 * *	 * -	 - -	 - -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 + *	 - *	 * *	 * -	2
2	51	CV	 	 * *	 * *	 * -	 - *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 + *	 * *	 * *	 * -	1
2	63	CV	 	 * *	 * *	 * -	 - +	 * +	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 + *	 * *	 * *	 * -	0
2	80	CV	 	 * *	 * *	 * -	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 * *	 - *	 * *	 * *	 - +	2
2	902	CV	 	 * *	 * *	 * -	 - -	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 + *	 * *	 * *	 + *	 * *	 * *	 * -	2
2	906	CV	 	 * *	 * *	 * -	 * -	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 + *	 * *	 * *	 + *	 * *	 * *	 * -	2
2	907	CV	 	 * *	 * *	 * -	 * -	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 - *	 * *	 * *	 * -	2
Total infection delay timee	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	16
Total number of contact-vaccinated birds	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	11
a-e: explanation below table of group 4









3	6	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 - +	 * *	 * *	 + +	 
3	7	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 
3	25	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 + +	 * *	 * *	 + +	 * *	 * *	 + +	 
3	43	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * -	 * *	 * *	 * -	 * *	 * *	 * -	 
3	52	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 * -	 * *	 * *	 + +	 
3	64	V	 	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 + *	 * *	 * *	 - +	 * *	 * *	 * +	 * *	 * *	 + +	 
3	70	V	 	 * -	 * +	 + *	 - *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * *	 * *	 * *	 * -	 * *	 * *	 * +	 
3	74	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 - +	 * *	 * *	 + +	 * *	 * *	 * -	 
3	75	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 + +	 * *	 * *	 * -	 
3	912	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 + *	 * *	 * *	 * -	 * *	 * *	 * -	 * *	 * *	 * -	 
3	928	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 + +	 * *	 * *	 + +	 * *	 * *	 - +	 
3	0	CV	 	 * *	 * *	 * -	 - -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 * *	 - *	 * *	 * *	 + +	1
3	8	CV	 	 * *	 * *	 * -	 + +	 * +	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 + *	 * *	 * *	 + +	0
3	30	CV	 	 * *	 * *	 * -	 * +	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 * *	 + *	 * *	 * *	 + +	0
3	32	CV	 	 * *	 * *	 * -	 * -	 * +	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 * *	 - *	 * *	 * *	 * *	1
3	45	CV	 	 * *	 * *	 * -	 * -	 - -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 - *	 * *	 * *	 * -	2
3	47	CV	 	 * *	 * *	 * -	 + +	 + +	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 - *	 * *	 * *	 + +	0
3	53	CV	 	 * *	 * *	 * -	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 - *	 * *	 * *	 * -	2
3	56	CV	 	 * *	 * *	 * -	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 * *	 - *	 * *	 * *	 * -	1
3	62	CV	 	 * *	 * *	 * -	 - -	 * +	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 + *	 * *	 * *	 * -	1
3	81	CV	 	 * *	 * *	 * -	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * -	2
3	88	CV	 	 * *	 * *	 * -	 - -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 - *	 * *	 * *	 + +	2
Total infection delay timee	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	12
Total number of contact-vaccinated birds	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	11













4	5	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 * +	 * *	 * *	 * -	 
4	23	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 * +	 * *	 * *	 * -	 
4	40	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 - *	 * *	 * *	 * -	 * *	 * *	 + +	 * *	 * *	 - +	 
4	60	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 + +	 * *	 * *	 * -	 
4	84	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 - +	 * *	 * *	 * -	 
4	85	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 * -	 * *	 * *	 - +	 
4	87	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 * +	 * *	 * *	 - +	 * *	 * *	 - +	 
4	96	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * -	 * *	 * *	 * -	 * *	 * *	 - +	 
4	910	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 - +	 * *	 * *	 * -	 
4	921	V	 	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 - *	 * *	 * *	 + +	 * *	 * *	 * -	 * *	 * *	 * +	 
4	922	V	 	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * +	 * *	 * *	 * +	 * *	 * *	 * -	 
4	10	CV	 	 * *	 * *	 * -	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 - *	 * *	 * *	 * -	1
4	15	CV	 	 * *	 * *	 * -	 * -	 * +	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 - +	1
4	38	CV	 	 * *	 * *	 * -	 * -	 - -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * -	3
4	48	CV	 	 * *	 * *	 * -	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 * *	 - *	 * *	 * *	 * -	2
4	54	CV	 	 * *	 * *	 * -	 * -	 * +	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 + *	 - *	 * *	 * *	 - *	 * *	 * *	 - +	1
4	59	CV	 	 * *	 * *	 * -	 * -	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - +	2
4	73	CV	 	 * *	 * *	 * -	 * -	 - +	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * *	 * *	 * -	1
4	97	CV	 	 * *	 * *	 * -	 * -	 * +	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 * *	 + *	 * *	 * *	 * -	1
4	98	CV	 	 * *	 * *	 * -	 * -	 * -	 * +	 + *	 + *	 + *	 - *	 + *	 - *	 + *	 + *	 - *	 * *	 * *	 - *	 * *	 * *	 * -	2
4	903	CV	 	 * *	 * *	 * -	 * -	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 + *	 * *	 * *	 + +	2
4	917	CV	 	 * *	 * *	 * -	 * -	 * -	 * +	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 * *	 + +	2
Total infection delay timee	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	18
Total number of contact-vaccinated birds	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	11
Oocyst output data following each V and CV bird: the first symbol represents the results of McMaster oocyst counts, the second symbol shows the result of sedimentation– flotation slides: +: oocysts were detected, *: not done, -: no oocysts were detected.
a. Individual animal number and vaccination state, b. Day of the experiment, c. Day post vaccination, d. Infection delay time = the number of days between the first day when it is considered possible for a CV bird to start excreting oocysts and the first day the CV bird actually started to excrete oocysts, e. Sum of the infection delay times for all CV birds together


Appendix 3 Oocyst output results of the McMaster counting chamber and sedimentation–flotation technique for the challenge period





1a	41	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 * *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 * *	0
1a	44	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 - +	 * *	0
1a	58	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 * *	0
1a	930	NV-Cont	 	 * *	 * -	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 - +	0
1a	933	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 - *	 * *	0
1a	37	NV-Ino	 	 * -	 * -	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 + *	 * *	 - -	 * *	 
1a	39	NV-Ino	 	 * -	 * *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 * *	 + *	 + *	 
1a	99	NV-Ino	 	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 
1a	911	NV-Ino	 	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 
1a	932	NV-Ino	 	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 * *	 + *	 
Total infection delay contact-challenged birdse	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0
Total number of contact-challenged birds	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	5
 	 	 	Dayb	31	32	33	34	35	36	37	38	39	40	41	42	43	44	45	46	47	48	49	Infection delay timed
Group	Birdnra	Typea	Daypic	29	30	31	32	33	34	35	36	37	38	39	40	41	42	43	44	45	46	47	
1b	69	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 + *	 - *	 * *	 - *	 * -	 * *	0
1b	71	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 - *	 + *	 + *	0
1b	909	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 + *	 + *	 * *	0
1b	914	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	0
1b	916	NV-Cont	 	 * -	 * *	 * *	 * *	 + +	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	0
1b	1	NV-Ino	 	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 + +	 * *	 
1b	4	NV-Ino	 	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 * -	 * *	 
1b	17	NV-Ino	 	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 
1b	24	NV-Ino	 	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 
1b	33	NV-Ino	 	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 + *	 
Total infection delay contact-challenged birdse	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0
Total number of contact-challenged birds	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	5
a-e: explanation below table of group 4 in appendix 2







2a	12	V-Cont	 	 * -	 * *	 * *	 * *	 * -	 * -	 - -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 * *	3
2a	21	V-Cont	 	 * -	 * *	 * *	 * *	 * -	 - +	 - -	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 - -	1
2a	28	V-Cont	 	 * *	 * -	 * *	 * *	 * -	 - -	 - -	 * -	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 + *	4
2a	35	V-Cont	 	 * -	 * *	 * *	 * *	 + +	 - +	 - -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 - -	 * *	0
2a	95	V-Cont	 	 * -	 * *	 * *	 * *	 * -	 - +	 + +	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 - +	 * *	1
2a	11	V-Ino	 	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 - *	 * *	 - -	 * *	 
2a	61	V-Ino	 	 * -	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - +	 * *	 
2a	76	V-Ino	 	 * -	 + +	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - +	 * *	 
2a	83	V-Ino	 	 * -	 * -	 * -	 + +	 + *	 + +	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 * *	 + *	 * *	 - *	 * -	 * *	 
2a	925	V-Ino	 	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - -	 * *	 
Total infection delay contact-challenged birdse	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	9




2b	3	CV-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 - -	 * *	0
2b	18	CV-Cont	 	 * -	 * *	 * *	 * *	 * -	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 + *	 * *	1
2b	19	CV-Cont	 	 * -	 * *	 * *	 * *	 + +	 - *	 - -	 - -	 * +	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 - *	 - -	 * *	0
2b	34	CV-Cont	 	 - -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 * -	 * *	0
2b	80	CV-Cont	 	 * -	 * *	 * *	 * *	 + +	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	 * *	0
2b	31	CV-Ino	 	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - -	 * *	 
2b	51	CV-Ino	 	 * -	 + +	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - -	 * *	 
2b	902	CV-Ino	 	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 + +	 * *	 
2b	906	CV-Ino	 	 * -	 - +	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 + *	 * *	 - -	 * *	 
2b	907	CV-Ino	 	 * -	 - +	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 - +	 * *	 
Total infection delay contact-challenged birdse	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1
Total number of contact-challenged birds	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	5
a-e: explanation below table of group 4 in appendix 2







3a	43	V-Cont	 	 * -	 * *	 * *	 * *	 + +	 - +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 - *	 * *	0
3a	52	V-Cont	 	 * -	 * *	 * *	 * *	 + +	 * +	 + *	 + *	 + *	 * *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 * *	0
3a	74	V-Cont	 	 * -	 * *	 * *	 * *	 + +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 * *	0
3a	75	V-Cont	 	 * *	 * -	 * *	 * *	 + +	 + *	 - -	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 - *	 * *	 + *	 + *	 * *	0
3a	928	V-Cont	 	 * -	 * *	 * *	 * *	 + +	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 + *	 + *	0
3a	6	V-Ino	 	 * -	 + +	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 
3a	25	V-Ino	 	 * -	 + +	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 + *	 
3a	64	V-Ino	 	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 
3a	70	V-Ino	 	 * -	 - +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 
3a	912	V-Ino	 	 * -	 - +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - -	 * *	 
Total infection delay contact-challenged birdse	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0




3b	30	CV-Cont	 	 * -	 * *	 * *	 * *	 - +	 - -	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 - +	 * *	0
3b	45	CV-Cont	 	 * -	 * *	 * *	 * *	 + +	 - +	 + *	 + *	 * +	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 - -	 * *	0
3b	53	CV-Cont	 	 * -	 * *	 * *	 * *	 + +	 * *	 + *	 + *	 + *	 * *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 - -	 * *	0
3b	56	CV-Cont	 	 * -	 * *	 * *	 * *	 * -	 - +	 - -	 + *	 + *	 * *	 + *	 + *	 + *	 + *	 + *	 * *	 - *	 - +	 * *	1
3b	88	CV-Cont	 	 * -	 * *	 * *	 * *	 - +	 - -	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 - *	 * *	0
3b	0	CV-Ino	 	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 - -	 * *	 
3b	8	CV-Ino	 	 * *	 * -	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 * *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 - +	 * *	 
3b	47	CV-Ino	 	 * -	 * -	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 - *	 * *	 + *	 * *	 + *	 * *	 - -	 * *	 
3b	62	CV-Ino	 	 * -	 - +	 + +	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 + *	 * *	 
3b	81	CV-Ino	 	 * -	 * -	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 + *	 * *	 + *	 * *	 + *	 * *	 - *	 * *	 - +	 * *	 
Total infection delay contact-challenged birdse	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1
Total number of contact-challenged birds	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	5






Nr	Group 	Day of death	Remarks
7	Group 3	Died at 21-7	necropsy: no abnormalities
32	Group 3	Died at 31-7	necropsy: very autolytic
87	Group 4	Euthanized at 4-8	necropsy: cartilage plug on both tibia’s, feed in stomach and oesophagus, dark lungs 
78	Group 1	Euthanized at 6-8 (random)	necropsy: unilateral… [illegible]
29	Group 1	Euthanized at 6-8 (because of low weight (1010g))	necropsy: female
926	Group 2	Euthanized at 6-8 (random)	necropsy: no abnormalities
63	Group 2	Euthanized at 6-8 (doubtful transmission moment)	necropsy: cartilage plug
73	Group 4	Euthanized at 6-8 (doubtful transmission moment)	necropsy: no abnormalities
80	Group 2	Died at 11-8	necropsy: ascites (dilated right ventricle, fluid in abdomen), negative SF, no coccidiosis lesions
916	Group 1	Died at p 13-8	necropsy: female, many coccidiosis lesions in duodenum (score 3?)
914	Group 1	Died at 17-8 	necropsy: autolytic, foci in liver (big plagues of necrosis / no purulent foci: looked like necrotic tissue/fungal infection. Locally kind of balloon of capsula




Appendix 5 Stable design
Vaccination period stable A

Vaccination period stable B


Challenge period stable A

































































































































A. Vaccination state (0=NV, 1=CV, 2=V)
B. Number of birds per group
C. Day of the experiment
D. Meanlogauctotalcorr: the logauc for I birds of day 46 of the experiment and for CI birds logauc of day 49 was used as a measure for total output during the challenge period, corrected for the fact that I birds could start with oocyst excretion 3 days before CI birds.

a–b Values within the same column with different superscripts differ significantly (P < 0.05)

For body weight, the significances are expressed by cage differences, no division between CI or I is made. This is indicated by the double-lined boxes around each pair of CI and I animals from each cage.
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